NeuroDerm Initiates Phase 2 Study of ND0801 in Patients with ADD/ADHD

Published November 16, 2010

NeuroDerm Initiates Phase 2 Study of ND0801 in Patients with ADD/ADHD
NeuroDerm, Ltd. announced today that patient enrollment has begun in a Phase 2a clinical study of ND0801, a new product for the treatment of Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder in adults.
Read more on PR Newswire via Yahoo! Finance

Hall County officials concerned about prisoner release program
GRAND ISLAND – A state budget-cutting plan that calls for releasing inmates from overcrowded Nebraska prisons has Hall County officials worried.
Read more on Lexington Clipper-Herald

Tobacco lawsuit cites long-ago cigarette giveaways
Marie Evans recalled she was 9 years old when she first started getting free cigarettes in the Boston housing project where she lived.
Read more on San Diego Union-Tribune